Physicochemical Characterisation of Ceftobiprole and Investigation of the Biological Properties of Its Cyclodextrin-Based Delivery System
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262412108 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Dariusz Boczar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Synthetic Drugs, National Medicines Institute, Chełmska 30/34, 00-725 Warsaw, Poland. Hauptthemen laut MEDLINE: Cephalosporins, Anti-Bacterial Agents, Cyclodextrins, Drug Delivery Systems. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education, Polish Ministry of Science and Higher Education.
Abstract (Originalsprache)
Ceftobiprole is a novel and promising antibiotic; however, the direct pharmacological use of its native form is limited by its low water solubility. The first part of this study provides a deeper insight into the physicochemical properties of this drug. One- and two-dimensional nuclear magnetic resonance (NMR) spectra in D2O were recorded, and a complete assignment of 1H and 13C signals was achieved with the support of quantum mechanical calculations. The combined results from capillary electrophoresis and NMR confirmed the cationic nature of ceftobiprole at pH values well below 3 and the protonation of the secondary amino group, thus supporting the theoretically predicted dominant protonation states. Molecular dynamics simulations revealed that zwitterionic ceftobiprole molecules associate through hydrogen bonding, whereas in the cationic form, the attractive forces involve weaker π-π and stacking interactions. The use of ceftobiprole in its native form in pharmaceutical formulations was made possible through the development of a novel freeze-dried cyclodextrin-based delivery system. Consequently, the second part of this article focuses on evaluating the biological properties of this system (ceftobiprole/maleic acid/sulfobutylether-β-cyclodextrin in a molar ratio of 1:25:4), including its antibacterial activity against the most common pneumonia-causing pathogens and its cytotoxicity towards normal and cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Synthetic Drugs, National Medicines Institute, Chełmska 30/34, 00-725 Warsaw, Poland.
- Laboratory for Analysis of Bioactive Compounds, Institute of Organic Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, Poland.
- Department of Biomedical Research, National Medicines Institute, Chełmska 30/34, 00-725 Warsaw, Poland.
- Department of Pharmaceutical Microbiology and Bioanalysis, Medical University of Warsaw, Banacha 1b, 02-097 Warsaw, Poland.
ORCID-Profile: Dariusz Boczar, Wojciech Bocian, Krystian Małek, Małgorzata Milczarek, Agnieszka Ewa Laudy, Katarzyna Michalska
Förderung
- Ministry of Science and Higher Education
- Polish Ministry of Science and Higher Education
Zitieren
APA
Boczar, D., Bocian, W., Małek, K., Milczarek, M., Laudy, A. E., & Michalska, K. (2025). Physicochemical Characterisation of Ceftobiprole and Investigation of the Biological Properties of Its Cyclodextrin-Based Delivery System. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262412108
Vancouver
Boczar D, Bocian W, Małek K, Milczarek M, Laudy AE, Michalska K. Physicochemical Characterisation of Ceftobiprole and Investigation of the Biological Properties of Its Cyclodextrin-Based Delivery System. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262412108
BibTeX
@article{Boczar2025,
author = {Boczar, Dariusz and Bocian, Wojciech and Małek, Krystian and Milczarek, Małgorzata and Laudy, Agnieszka Ewa and Michalska, Katarzyna},
title = {Physicochemical Characterisation of Ceftobiprole and Investigation of the Biological Properties of Its Cyclodextrin-Based Delivery System},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262412108}
}
EUVIMED